A short study comparing countries on the quality of response to the Covid-19 pandemic
Thilakam Venkatapathi, Murugesan Venkatapathi

TL;DR
This study assesses and ranks countries based on their Covid-19 response quality during the first 18 months, using a robust method that considers deaths, testing, cases, and vaccinations, revealing many countries' outcomes were not significantly better than baseline expectations.
Contribution
It introduces a novel, robust method for evaluating Covid-19 response quality across countries, accounting for data uncertainties and demographic factors.
Findings
Many countries' outcomes are not significantly better than baseline.
The ranking method is robust to data uncertainties.
Adjustments for purchasing power and age distribution can refine rankings.
Abstract
Background: We estimate the overall quality of response to the Covid-19 pandemic in the first 18 months, using a small number of known parameters and a proposed method that is reasonably robust to the uncertainties in the data. Methods: The population-normalized values of deaths, diagnostic tests, confirmed cases, and doses of vaccines administered were considered. The average infection-fatality-rate provides us a baseline on potential deaths, and along with the test positivity rates in the formula, they add robustness to the estimates of the quality of response. Results: The scores are used to rank countries in two lists representing 84 large countries with a population greater than 10 million, and 85 countries with smaller populations. Additional possible corrections in the rankings of countries to include the per capita purchasing power and the age distribution, are also shown.…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCOVID-19 epidemiological studies · SARS-CoV-2 and COVID-19 Research · Viral Infections and Outbreaks Research
